Lila K. D.
- Country
- France
- Department
- EUROFINS OPTIMED
Research Overview
- Phase 1 Safety Study of HI-6 Dimethyl Sulfonate in Organophosphorus Poisoning via IV Bolus and Infusion in Healthy Volunteers
- Evaluation of Safety and Pharmacokinetics of BDT272 in Single and Multiple Ascending Doses in Healthy Volunteers with Moderate to Severe Pain
- Evaluation of Safety, Tolerability, and Pharmacokinetics of Intranasal CBT101 in Healthy Male Subjects with Neurological Disease: A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 1 of 1 partner site.
Specializations
Neurological Disorders
This investigator demonstrates significant involvement in research concerning neurodegenerative conditions and neurological disorders, with particular focus on Alzheimer's disease and Down Syndrome. Their work extends to evaluating novel therapeutic approaches for various neurological conditions.
- Alzheimer's Disease Research
- Down Syndrome Studies
- Neurological Disease Treatment
Rare Diseases
The investigator has conducted research in rare neurological conditions, specifically focusing on Dravet syndrome. Their work includes evaluation of different drug formulations and their bioavailability for treating these conditions.
- Dravet Syndrome Treatment
- Drug Formulation Studies
Emergency Medicine
The investigator's expertise extends to emergency medical interventions, particularly in the area of toxicology and pain management. Their research includes studies on treatments for organophosphorus poisoning and approaches to managing moderate to severe pain.
- Toxicology Treatment
- Pain Management
- Emergency Interventions
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.